Slashing American IP rights will needlessly hurt Delaware's biotech sector | Opinion
Without robust intellectual property protection, American biotech firms - including some in Delaware - won't be able to safely share innovations.
Without robust intellectual property protection, American biotech firms - including some in Delaware - won't be able to safely share innovations.